Effect of cinazepam administration on the ligand affinity of neuromediator system receptors in rat brain

Pharmaceutical Chemistry Journal

Volumn 41, Issue 5, 2007, Pages 249-252

  Makan, S Yu ^a   Boiko, I A ^a   Smul'skii, S P ^a   Andronati, S A ^a  

^a INSTITUTE OF HYDROBIOLOGY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CINAZEPAM; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HYPNOTIC AGENT; LIGAND; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG; ZOPICLONE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG EFFECT; LIGAND BINDING; MALE; NONHUMAN; RAT; RECEPTOR BINDING; SINGLE DRUG DOSE;

EID: 36448971623     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-007-0055-9     Document Type: Article

References (22)

1. UA Patent No. 19803, MPK7: C97D 243 / 14; A61K 31 / 55 (1997).
2. K. S. Andronati, T. L. Karaseva, L. V. Popova, et al., Visn. Psikhiatr. Farmakol., 1(5), 6-8 (2004).
3. A. M. Vein, Sleep Disturbances: Main Pathogenetic Mechanisms and Methods of Correction [in Russian], GEOTAR-Meditsina, Moscow (1995), pp. 6-12.
4. C. Bonnafous and L. Bueno, Pharmacol. Biochem. Behav., 49, 253-256 (1994).
5. I. V. Komissarov, A. T. Dolzhenko, and I. I. Abramets, Vestn. Akad. Med Nauk SSSR, 9, 26-30 (1984).
6. M. M. Mitler, Sleep, 23(1), S39-S46 (2000).
7. A. Plaznik, Pol. J. Pharmacol., 47, 489-499 (1995).
8. A. J. Dunn, Ann. N. Y. Acad. Sci., 537, 188-205 (1988).
9. R. A. Webster, Neurotransmitters, Drugs and Brain Function, Wiley, Chichester, New York, Weinheim, Brisbene, Singapore, Toronto (2001), p. 521.
10. R. Brus, R. Szkilnik, P. Novak, et al., Pharm. Rev. Com., 10920, 93-100 (1998).
11. L. Lima, E. Trejo, and M. Urbina, Neuropharm., 34(10), 1327-1333 (1995).
12. A. Feigenspan, S. Gustincich, and E. Raviola, J. Neurophysyol., 84, 1697 (2000).
13. V. M. Korkhov, N. A. Tkachuk, S. Yu. Makan, et al., J. Recept. Signal. Transduct. Res., 22(1-4), 411-420 (2002).
14. S. Andronati, V. Sava, S. Makan, et al., Pharmazie, 54(2), 99-101 (1999).
15. K. S. Andronati, S. Yu. Makan, G. E. Kolodeev, et al., Khim.-Farm. Zh., 35(11), 11-14 (2001).
16. S. Yu. Makan, N. A. Tkachuk, V. M. Korkhov, et al., Khim.-Farm. Zh., 39(6), 19-21 (2005).
17. L. Lanfumey, S. Haj-Dahmane, A. M. Laporte, et al., Eur. J. Pharmacol., 323(2-3), 137-148 (1997).
18. L. Giardino, L. Calza, P. V. Piazza and G. Amato, J. Neural. Transm. Gen. Sect., 83(3), 189-203 (1991).
19. J. Harro, M. Pold, and E. Vasar, Arch. Pharmacol., 341, 62-67 (1990).
20. I. A. Boiko, S. Yu. Makan, S. P. Smul'skii, and K. S. Andronati, Visn. Odess. Gos. Univ., 1, 49-57 (2005).
21. I. A. Boiko, S. Yu. Makan, S. P. Smul'skii, and K. S. Andronati, Farm. Zh., 5, 93-97 (2005).
22. Molecular Principles of Action of Psychotropic Drugs [in Russian], Moscow (1986), pp. 94-102.